General Knowledge MCQs
Topic Notes: General Knowledge
MCQs and preparation resources for competitive exams, covering important concepts, past papers, and detailed explanations.
Plato
- Biography: Ancient Greek philosopher (427–347 BCE), student of Socrates and teacher of Aristotle, founder of the Academy in Athens.
- Important Ideas:
- Theory of Forms
- Philosopher-King
- Ideal State
31
Which drug was approved in September 2025 for the treatment of acromegaly in adults who had an inadequate response to surgery?
Answer:
Palsonify (paltusotine)
Palsonify (paltusotine) was approved in September 2025 as an oral treatment for acromegaly, a hormonal disorder, specifically for patients who could not be cured by surgery.
32
In June 2025, which country cleared gene-edited, reduced-browning bananas for commercial release to reduce food waste?
Answer:
Philippines
The Philippines government cleared gene-edited bananas developed by Tropic Biosciences in June 2025. These bananas are engineered to brown less quickly, which aims to significantly reduce food waste and associated carbon emissions.
33
Researchers at St. Jude Children's Research Hospital launched which database in November 2025 to keep protein structure predictions up to date?
Answer:
AlphaSync
St. Jude scientists launched the AlphaSync database in November 2025. This resource is designed to keep protein structure predictions current, helping to prevent cascading errors in research that relies on outdated models.
34
Which company was acquired by Amazon to bolster its AI wearable technology, specifically known for a wristband called 'Bee'?
Answer:
Bee
Reports in 2025 indicated that Amazon acquired the startup 'Bee', known for its AI wearable wristband, to integrate its ambient intelligence capabilities into Amazon's product ecosystem.
35
What type of robot, often referred to as a 'MoMa', became a significant trend in industrial robotics in 2025?
Answer:
Mobile Manipulator
Mobile Manipulators, or 'MoMas', emerged as a major trend in 2025. They combine a robotic arm with a mobile base (AMR), allowing the robot to move around a facility and perform complex handling tasks at different locations.
36
A November 2025 study indicated that combining Tirzepatide and Semaglutide provided strong protection against which major health event?
Answer:
Heart attack and stroke
A massive real-world study in November 2025 revealed that both Tirzepatide and Semaglutide (GLP-1 drugs) deliver strong cardiovascular protection, significantly reducing the risk of heart attack, stroke, and death in adults with type 2 diabetes.
37
Which drug received FDA approval in September 2025 for the treatment of chronic spontaneous urticaria?
Answer:
Rhapsido (remibrutinib)
Rhapsido (remibrutinib) was approved by the FDA in September 2025 for treating chronic spontaneous urticaria in adults who remain symptomatic despite antihistamine treatment.
38
In November 2025, a study found that which common amino acid supplement could significantly reduce amyloid-beta aggregation in Alzheimer's disease models?
Answer:
Arginine
A study published in November 2025 discovered that the amino acid arginine can block harmful amyloid-beta aggregation and reduce its toxic effects in Alzheimer's disease models, suggesting a potential simple therapeutic intervention.
39
Researchers in November 2025 created a 'miniature' version of which human body system to study blood production and diseases like leukemia?
Answer:
Bone Marrow
Scientists successfully engineered a miniature human bone marrow system in the lab in November 2025. This organoid mirrors the real structure of bone marrow and supports blood cell production, providing a new model for studying blood diseases.
40
Which tool, described in Nature Communications in 2025, uses AI to identify relevant clinical trials for patients and explain their eligibility?
Answer:
TrialGPT
TrialGPT is an AI algorithm highlighted in 2025 that successfully identifies relevant clinical trials for patients and provides summaries explaining how they meet the enrollment criteria, facilitating better access to experimental treatments.